• 1. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 4. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 5. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381

Recent Advances in the Application of Methyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate (CAS: 110860-60-1) in Chemical Biology and Pharmaceutical Research

Methyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate (CAS: 110860-60-1) is a pyrazole derivative that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various biologically active molecules, including potential drug candidates. The unique structural features of this compound, such as the amino and ester functional groups, make it a valuable building block for the development of novel therapeutic agents. Recent studies have explored its utility in medicinal chemistry, particularly in the design of kinase inhibitors, antimicrobial agents, and anti-inflammatory compounds.

One of the most notable advancements in the application of Methyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate is its role in the synthesis of kinase inhibitors. Kinases are critical targets in the treatment of various diseases, including cancer and inflammatory disorders. Researchers have successfully utilized this compound to develop potent and selective kinase inhibitors by modifying its core structure. For instance, a recent study published in the Journal of Medicinal Chemistry demonstrated the synthesis of a series of pyrazole-based inhibitors targeting the JAK2 kinase, which is implicated in myeloproliferative neoplasms. The study highlighted the importance of the amino and ester groups in enhancing the binding affinity and selectivity of the inhibitors.

In addition to its applications in kinase inhibitor development, Methyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate has also been investigated for its antimicrobial properties. A study conducted by a team of researchers from the University of Cambridge explored the compound's potential as a scaffold for designing novel antibacterial agents. The researchers synthesized a library of derivatives and evaluated their activity against a panel of Gram-positive and Gram-negative bacteria. The results indicated that certain derivatives exhibited promising antibacterial activity, particularly against methicillin-resistant Staphylococcus aureus (MRSA). This finding underscores the compound's potential in addressing the growing challenge of antibiotic resistance.

Another area of research where Methyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate has shown promise is in the development of anti-inflammatory agents. A recent study published in Bioorganic & Medicinal Chemistry Letters reported the synthesis of pyrazole derivatives with potent anti-inflammatory activity. The researchers found that modifications to the amino and ester groups of the compound significantly influenced its ability to inhibit pro-inflammatory cytokines. These findings suggest that Methyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate could serve as a valuable starting point for the design of new anti-inflammatory drugs.

Despite the promising applications of Methyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate, challenges remain in optimizing its pharmacological properties. For example, issues related to solubility, bioavailability, and metabolic stability need to be addressed to enhance its therapeutic potential. Recent efforts have focused on structural modifications to improve these properties. A study published in European Journal of Medicinal Chemistry described the synthesis of water-soluble derivatives of the compound, which exhibited improved pharmacokinetic profiles. Such advancements are critical for translating the compound's potential into clinically viable therapeutics.

In conclusion, Methyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate (CAS: 110860-60-1) represents a versatile and valuable scaffold in chemical biology and pharmaceutical research. Its applications in the development of kinase inhibitors, antimicrobial agents, and anti-inflammatory compounds highlight its broad utility. Ongoing research efforts aimed at optimizing its pharmacological properties are expected to further expand its therapeutic potential. As the field continues to evolve, this compound is likely to play an increasingly important role in the discovery and development of novel drugs.

• 112665-43-7(Seratrodast)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)